Australia is trying to develop a local vaccine against bovine trichomoniasis

Published 2023년 2월 28일

Tridge summary

The University of Queensland has developed an experimental vaccine for bovine trichomoniasis, a disease that leads to infertility in cattle. The disease was found in bulls from all major Australian livestock regions, with losses from reproductive inefficiencies costing the industry between $60 million and $100 million annually. Currently, the use of imported vaccines is often inappropriate due to safety concerns, making a locally produced vaccine necessary. The vaccine has been successfully tested on a small group of bulls, with larger trials planned.
Disclaimer:The above summary was generated by Tridge's proprietary AI model for informational purposes.

Original content

The University of Queensland has announced the creation of an experimental vaccine against trichomoniasis in cattle (cattle). This was reported in a publication on the university website. Trichomoniasis of cattle is a disease that causes infertility in cattle. In a study by Professor Michael McGowan of the University of Queensland's School of Veterinary Medicine, the infection was found in slaughterhouse bulls from all of Australia's major livestock regions and in one in ten animals from the northern territories of the country. Bulls are reported to infect cows during mating, causing them to become infertile or have abortions. According to Dr. Kieren McCosker, who helped collect samples for the study, in northern Australian herds, losses from reproductive inefficiencies cost the industry between $60 million and $100 million a year. At the same time, the use of imported vaccines against bovine trichomoniasis is often inappropriate, as this affects the safety of ...
Source: Milknews

Would you like more in-depth insights?

Gain access to detailed market analysis tailored to your business needs.
By clicking “Accept Cookies,” I agree to provide cookies for statistical and personalized preference purposes. To learn more about our cookies, please read our Privacy Policy.